Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Jul 1;19(7):e0306658. doi: 10.1371/journal.pone.0306658

Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment

Adam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, Subash Baniya, Zachary A Cooper, Adriano Piris, Leeza Hargreaves, Vivien Igras, Dennie T Frederick, Donald P Lawrence, Daniel A Haber, Keith T Flaherty, Jennifer A Wargo, Sridhar Ramaswamy, Cyril H Benes, David E Fisher
PMCID: PMC11216593  PMID: 38950005

There is an error in S3 Table. Some data in the columns are duplicated. Please view the correct S3 Table below.

Supporting information

S3 Table

(XLSX)

pone.0306658.s001.XLSX (24.2MB, XLSX)

Reference

  • 1.Friedman AA, Amzallag A, Pruteanu-Malinici I, Baniya S, Cooper ZA, Piris A, et al. (2015) Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment. PLoS ONE 10(10): e0140310. doi: 10.1371/journal.pone.0140310 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S3 Table

(XLSX)

pone.0306658.s001.XLSX (24.2MB, XLSX)

Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES